Search Menu
Photonics Media Photonics Marketplace Photonics Spectra BioPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook

Company Receives Integrated Optical Biosensor

Facebook Twitter LinkedIn Email
Biomagnetics Diagnostics Corp., based in Orangevale, Calif., has accepted delivery of a biosensor proposed for use in diagnosing cholera, tuberculosis and malaria. The sensor could be in clinical trials by 2012. Developed in conjunction with scientists and engineers at Los Alamos National Laboratory in New Mexico, the device could allow relatively untrained medical personnel to diagnose a variety of diseases rapidly. The biosensor uses planar waveguides to bring protein-receptor pairs into proximity with one another, thus triggering detectable fluorescence. The California company plans to commercialize the sensor, which was created through a cooperative research and development agreement with Los Alamos National Security LLC.

Photonics Spectra
Jul 2011
The emission of light or other electromagnetic radiation of longer wavelengths by a substance as a result of the absorption of some other radiation of shorter wavelengths, provided the emission continues only as long as the stimulus producing it is maintained. In other words, fluorescence is the luminescence that persists for less than about 10-8 s after excitation.
AmericasBiomagnetics Diagnostics Corp.BiophotonicsbiosensorBusinessCaliforniacholeraClayton Hardmanclinical trialsdefensefluorescenceimaginglight speedLos Alamos National LaboratoryLos Alamos National Security LLCmalaria diagnosisopticsplanar waveguidesprotein-receptor pairsSan FranciscoSensors & Detectorstuberculosis

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2023 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

Photonics Media, Laurin Publishing
x Subscribe to Photonics Spectra magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.